Autolus Therapeutics Highlights Updated Manufacturing Facility Strategy For Commercial Supply Of AUTO1
Autolus Therapeutics Highlights Updated Manufacturing Facility Strategy For Commercial Supply Of AUTO1
Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced its updated manufacturing facilities strategy for commercial supply of AUTO1.
Autolus now plans to establish global commercial launch capacity in the UK, enabling the company to leverage the expertise and skill base of its U.K. employees. This will be provided by a combination of the existing clinical trial manufacturing facility at The Cell and Gene Therapy Catapult (CGTC) facility and a new Autolus facility. This revised strategy aims to deliver a less capital-intensive commercial manufacturing infrastructure at a lower cost base.
In conjunction with this new facilities strategy, Autolus' lease for the manufacturing and office facility at 9950 Medical Center Drive in Rockville, MD, has been mutually terminated, triggering a cash payment to Autolus and ending all of the company's payment obligations under the lease.
Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced its updated manufacturing facilities strategy for commercial supply of AUTO1.
Autolus Treeutics Plc(纳斯达克:AUTL),一家开发下一代程序化T细胞疗法的临床阶段生物制药公司,今天宣布其针对AUTO1商业供应的最新制造设施战略。
Autolus now plans to establish global commercial launch capacity in the UK, enabling the company to leverage the expertise and skill base of its U.K. employees. This will be provided by a combination of the existing clinical trial manufacturing facility at The Cell and Gene Therapy Catapult (CGTC) facility and a new Autolus facility. This revised strategy aims to deliver a less capital-intensive commercial manufacturing infrastructure at a lower cost base.
Autolus现在计划在英国建立全球商业发射能力,使该公司能够利用其英国员工的专业知识和技能基础。这将由细胞和基因治疗弹射器(CGTC)设施的现有临床试验制造设施和一个新的Autolus设施相结合来提供。这一修订后的战略旨在以更低的成本基础提供资本密集度较低的商业制造业基础设施。
In conjunction with this new facilities strategy, Autolus' lease for the manufacturing and office facility at 9950 Medical Center Drive in Rockville, MD, has been mutually terminated, triggering a cash payment to Autolus and ending all of the company's payment obligations under the lease.
随着这一新设施战略的实施,Autolus对马里兰州罗克维尔医疗中心大道9950号的制造和办公设施的租约已经终止,从而触发了向Autolus支付现金,并终止了该公司根据租约承担的所有付款义务。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧